| 영문 | heparin | 한글 | 헤파린 |
|---|---|---|---|
| 설명 | 혈액 응고를 막는 작용을 하는 다당류의 황산에스테르. 고등동물의 각종 조직에 널리 분포되어 있으며, 수술 후의 혈전증을 막는 데 쓴다. 혈액응고란 지혈의 한 과정으로 섬유소란 물질을 만들어 내는 과정이다. 이 섬유소는 손상된 혈관의 부위에 작용하여 여러 가지 세포들을 얽어 묶는 역할을 하여 결국 손상된 혈관에서 혈액의 소실을 막는다. 이 섬유소는 트롬빈에 의해 섬유소원에서 전환된다. 헤파린이라는 물질은 이 트롬빈을 억제하는 항트롬빈을 활성화하는 물질이다. |
||
| BH | base hospital; benzalkonium and heparin; bill of health; birth history; Bishop-Harman [instruments];... |
|---|---|
| CH | case history; Chediak-Higashi [syndrome]; chiasma; Chinese hamster; chloral hydrate; cholesterol; Ch... |
| GBH | gamma-benzene hexachloride; graphite benzalkonium-heparin |
| HAREM | heparin assay rapid easy method |
| HARM | heparin assay rapid method |
| LMW heparin | Low Molecular Weight heparin |
|---|---|
| HEP | 1--heparin |
| HSPG | heparin sulfate proteoglycan |
| H | Heparin |
| HE | Heparin |
| heparin | <drug> Sulphated mucopolysaccharide, found in granules of mast cells, that inhibits the action of thrombin on fibrinogen by potentiating antithrombins, thereby interfering with the blood clotting cascade. Platelet factor IV will neutralise heparin. (18 Nov 1997) |
|---|---|
| heparin antagonists | Coagulant substances inhibiting the anticoagulant action of heparin. (12 Dec 1998) |
| heparin binding growth factor | <growth factor> Acidic fibroblast growth factor (alpha FGF, HBGF 1) and basic FGF (beta FGF, HBGF 2) are the two founder members of a family of structurally related growth factors for mesodermal or neuroectodermal cells. Synonym: heparin binding growth factor. Acronym: FGF (18 Nov 1997) |
| heparin cofactor II | <chemical> A sulfated plasma protein with the mw of approximately 66kda. The protein is an inhibitor of thrombin in plasma that is activated by dermatan sulfate or heparin. It is a member of the serpin superfamily. Pharmacological action: serine proteinase inhibitors. Chemical name: Heparin cofactor II (12 Dec 1998) |
| heparin complement | The protein component of heparin in blood. (05 Mar 2000) |
| heparin eliminase | <enzyme> An enzyme of the isomerase class that catalyses the eliminative cleavage of polysaccharides containing 1,4-linked d-glucuronate or l-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-d-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-d-gluc-4-enuronosyl groups at their non-reducing ends. Chemical name: heparin lyase Registry number: EC 4.2.2.7 (12 Dec 1998) |
| heparin lyase | <enzyme> An enzyme of the isomerase class that catalyses the eliminative cleavage of polysaccharides containing 1,4-linked d-glucuronate or l-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-d-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-d-gluc-4-enuronosyl groups at their non-reducing ends. Chemical name: heparin lyase Registry number: EC 4.2.2.7 (12 Dec 1998) |
| heparin unit | The quantity of heparin required to keep 1 ml of cat's blood fluid for 24 hr at 0캜; it is equivalent approximately to 0.002 mg of pure heparin. Synonym: Howell unit. (05 Mar 2000) |
| heparin, low-molecular-weight | <chemical> Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of haemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. Pharmacological action: anticoagulant, fibrinolytic agent. (12 Dec 1998) |
| heparin-glucosamine 3-O-sulfotransferase | <enzyme> Reaction: 3'-phosphoadenylylsulfate + heparin-glucosamine = adenosine 3',5'-bisphosphate + heparin glucosamine 3-o-sulfate Registry number: EC 2.8.2.23 Synonym: glucosaminyl 3-o-sulfotransferase, d-glucosaminyl 3-o-sulfotransferase (26 Jun 1999) |
| heparinaemia | The presence of demonstrable levels of heparin in the circulating blood. (05 Mar 2000) |
| heparinase | <enzyme> An enzyme of the isomerase class that catalyses the eliminative cleavage of polysaccharides containing 1,4-linked d-glucuronate or l-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-d-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-d-gluc-4-enuronosyl groups at their non-reducing ends. Chemical name: heparin lyase Registry number: EC 4.2.2.7 (12 Dec 1998) |
| heparinic acid | <drug> Sulphated mucopolysaccharide, found in granules of mast cells, that inhibits the action of thrombin on fibrinogen by potentiating antithrombins, thereby interfering with the blood clotting cascade. Platelet factor IV will neutralise heparin. (18 Nov 1997) |
| heparinise | To perform therapeutic administration of heparin. (05 Mar 2000) |
| heparinoids | <chemical> Heparin derivatives. The term has also been used more loosely to include naturally occurring and synthetic highly-sulphated polysaccharides of similar structure. Heparinoid preparations have been used for a wide range of applications including as anticoagulant and anti-inflammatories and they have been claimed to have hypolipidemic properties. Pharmacological action: anti-inflammatory agents, anticoagulant. (12 Dec 1998) |
Synonyms : Liquaemin, Sodium Heparin, Heparin, Sodium, alpha Heparin
Synonyms : Antagonists, Heparin
Synonyms : Heparin Co-Factor II, Co-Factor II, Heparin, Cofactor II, Heparin, Heparin Co Factor II
Synonyms : Neutralase, Eliminase, Heparin, I, Heparinase, Lyase, Heparin
Synonyms : Low Molecular Weight Heparin, Heparin, Low Molecular Weight
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
중외헤파린나트륨주사액1,000단위 - 새창
|
중외 |
A02104111 | Heparin sodium | 전문의약품 | 급여 | 분업예외의약품 |
|
메디텍헤파린나트륨주사액25,000단위 - 새창
|
한국메디텍 |
A20500531 | Heparin sodium | 전문의약품 | 삭제 | 분업예외의약품 |
|
한림헤파린나트륨주25,000단위 - 새창
|
한림제약 |
A37800521 | Heparin sodium | 전문의약품 | 급여 |
|
중외헤파린주사액 - 새창
|
중외 |
A02101541 | Heparin sodium | 전문의약품 | 급여 | 분업예외의약품 |
|
신풍헤파린나트륨주25,000단위 - 새창
|
신풍제약 |
A00302871 | Heparin sodium | 전문의약품 | 급여 | 분업예외의약품 |
|
메디텍헤파린나트륨주사액1,000단위 - 새창
|
한국메디텍 |
A20500541 | Heparin sodium | 전문의약품 | 삭제 | 분업예외의약품 |
|
유영헤파린칼슘주 - 새창
|
유영제약 |
A34002541 | Heparin calcium | 전문의약품 | 삭제 | 분업예외의약품 |
|
애보트헤파린나트륨주10000단위 - 새창
|
Abbott |
W01860131 | Heparin sodium | 전문의약품 | 삭제 |
|
녹십자상아헤파린나트륨주사액 - 새창
|
녹십자 |
A35540521 | Heparin sodium | 전문의약품 | 급여 |
|
헬핀주사 - 새창
|
비씨월드제약 |
A16250811 | Heparin sodium | 전문의약품 | 삭제 | 분업예외의약품 |
| heparin |
a polysaccharide produced in basophils (especially in the lung and liver) and that inhibits the activity of thrombin in coagulation of the blood; it (trade names Lipo-Hepin and Liquaemin) is used as an anticoagulant in the treatment of thrombosis and in heart surgery
출처: wordnet.princeton.edu/perl/webwn
|
|---|---|
| heparin cofactor II |
a serine proteinase inhibitor of the serpin family; it is a single-chain glycoprotein, M r 65,000, that inhibits thrombin. It resembles antithrombin III in being markedly stimulated by heparin; it differs in that it binds and is activated by dermatan sulfate and in that it does not inhibit any other activated coagulation factors.
출처: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
| heparin |
A naturally occurring mucopolysaccharide that acts in the body as an antithrombin factor to prevent intravascular clotting. Heparin is used therapeutically as an anticoagulant.
출처: virtualtrials.com/dictionary.cfm
|
| heparin |
A drug that helps prevent blood clots from forming.
출처: nydailynews.healthology.com/nydailynews/15836.htm
|
| heparin |
A drug that decreases the blood's ability to clot.
출처: www.thebody.com/hivnews/aidscare/dec97/pullout.htm...
|
| Heparin | a polysaccharide produced in basophils (especially in the lung and liver) and that inhibit the activity of thrombin in coagulation of the blood |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
